Clinical significance of serum thrombospondin-4 for interventional restenosis in diabetes patients complicated by lower extremity arteriosclerosis obliterans

doi:10.4239/wjd.124271

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 10

This Article

(11)

(9)

(0)

(40)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Diabetes. Oct 15, 2026; 17(10): 124271
Published online Oct 15, 2026. doi: 10.4239/wjd.124271

Full Size Figure Download Figure

Figure 6 Decision curve analysis of the prediction model. A: Training cohort; B: Validation cohort. Yellow curve: Treat all strategy; Black horizontal line: Treat none strategy; Blue curve: Nomogram.

Citation: Hu D, Lin XY, Zhao TQ, Ji H, Chen MW, Zhao XT. Clinical significance of serum thrombospondin-4 for interventional restenosis in diabetes patients complicated by lower extremity arteriosclerosis obliterans. World J Diabetes 2026; 17(10): 124271
URL: https://www.wjgnet.com/1948-9358/full/v17/i10/124271.htm
DOI: https://dx.doi.org/10.4239/wjd.124271

Hu D, Lin XY, Zhao TQ, Ji H, Chen MW, Zhao XT. Clinical significance of serum thrombospondin-4 for interventional restenosis in diabetes patients complicated by lower extremity arteriosclerosis obliterans. World J Diabetes 2026; 17(10): 124271 [DOI: 10.4239/wjd.124271]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.